이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Edwards PASCAL 경피적 판막 수리 시스템 Pivotal 임상 시험 (CLASP II TR)

2026년 11월 13일 업데이트: Edwards Lifesciences

삼첨판 역류가 있는 환자에서 OMT 단독 요법과 비교하여 Edwards PASCAL 경피적 경피적 판막 수리 시스템 및 최적의 의료 요법(OMT)을 사용한 경피적 삼첨판 치료의 안전성과 유효성을 평가하기 위한 전향적, 다기관, 무작위, 통제 중추 임상시험

To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team

연구 개요

상태

모집하지 않고 적극적으로

정황

개입 / 치료

상세 설명

A Prospective, multicenter, randomized, controlled pivotal trial to evaluate the safety and effectiveness of transcatheter tricuspid valve repair with the Edwards PASCAL Transcatheter Valve Repair System and optimal medical therapy (OMT) compared to OMT alone in patients with tricuspid regurgitation. Patients will be seen for follow-up visits at discharge, 30 days, 3 months, 6 months, and annually through 5 years.

연구 유형

중재적

등록 (추정된)

1270

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Arizona
      • Phoenix, Arizona, 미국, 85006
        • Banner University Medical Center Phoenix
      • Tucson, Arizona, 미국, 85712
        • Tucson Medical Center Healthcare
    • California
      • Irvine, California, 미국, 92868
        • University of California, Irvine
      • La Jolla, California, 미국, 92037
        • SCPMG - Kaiser San Diego
      • Los Angeles, California, 미국, 90048
        • Cedars Sinai Medical Center
      • Los Angeles, California, 미국, 90095
        • UCLA Medical Center
      • San Francisco, California, 미국, 94143
        • University of California, San Francisco
      • San Francisco, California, 미국, 94118
        • Kaiser Permanente San Francisco
      • Stanford, California, 미국, 94305
        • Stanford University
    • Colorado
      • Denver, Colorado, 미국, 80218
        • St. Joseph Hospital
      • Loveland, Colorado, 미국, 80538
        • Medical Center of the Rockies
    • Florida
      • Gainesville, Florida, 미국, 32605
        • The Cardiac and Vascular Institute Research Foundation
      • Miami Beach, Florida, 미국, 33140
        • Mount Sinai Medical Center
      • Naples, Florida, 미국, 34102
        • NCH Healthcare System
      • Sarasota, Florida, 미국, 34239
        • Sarasota Memorial Health Care System
      • Tallahassee, Florida, 미국, 32308
        • Tallahassee Research Institute
    • Georgia
      • Atlanta, Georgia, 미국, 30309
        • Piedmont Healthcare, Inc.
      • Atlanta, Georgia, 미국, 30308
        • Emory University Hospital Midtown / Emory University - St. Joseph's Hospital
    • Illinois
      • Chicago, Illinois, 미국, 60611
        • Northwestern University
    • Indiana
      • Indianapolis, Indiana, 미국, 46290
        • Ascension St. Vincent Heart Center Cardiovascular Research Institute
    • Iowa
      • Iowa City, Iowa, 미국, 52242
        • University of Iowa Hospitals & Clinics
    • Louisiana
      • New Orleans, Louisiana, 미국, 70121
        • Ochsner Medical Center
    • Maryland
      • Baltimore, Maryland, 미국, 21287
        • Johns Hopkins
    • Massachusetts
      • Boston, Massachusetts, 미국, 02114
        • Massachusetts General Hospital
    • Michigan
      • Ann Arbor, Michigan, 미국, 48109
        • University of Michigan
      • Detroit, Michigan, 미국, 48202
        • Henry Ford Hospital
      • Royal Oak, Michigan, 미국, 48073
        • William Beaumont Hospital - Royal Oak
      • Saginaw, Michigan, 미국, 48601
        • St. Mary's of Ascension Research
    • Minnesota
      • Maplewood, Minnesota, 미국, 55109
        • Fairview Health Services
      • Rochester, Minnesota, 미국, 55905
        • Mayo Clinic
    • Missouri
      • Kansas City, Missouri, 미국, 64111
        • Saint Luke's Hospital of Kansas City
      • St Louis, Missouri, 미국, 63110
        • Washington University School of Medicine
    • Montana
      • Missoula, Montana, 미국, 59802
        • Providence St. Patrick Hospital
    • New Hampshire
      • Lebanon, New Hampshire, 미국, 03756
        • Dartmouth-Hitchcock Medical Center
    • New Jersey
      • Camden, New Jersey, 미국, 09103
        • Cooper Health Systems
      • Morristown, New Jersey, 미국, 07962
        • Morristown Medical Center
      • New Brunswick, New Jersey, 미국, 08901
        • Rutgers Robert Wood Johnson Medical School
    • New York
      • Buffalo, New York, 미국, 14203
        • State University of New York at Buffalo
      • New York, New York, 미국, 10065
        • Weill Cornell Medicine
      • New York, New York, 미국, 10032
        • Columbia University Irving Medical Center/NYPH
      • New York, New York, 미국, 10075
        • Lenox Hill Hospital, Northwell Health /Northshore University Hospital Manhasset
      • Rochester, New York, 미국, 14621
        • Rochester General Hospital
      • Roslyn, New York, 미국, 11576
        • St. Francis Hospital
      • The Bronx, New York, 미국, 10467
        • Montefiore Medical Center / Arts Pavilion / Hutchinson Metro Center Clinic / Weiler Hospital / Moses Hospital
    • North Carolina
      • Chapel Hill, North Carolina, 미국, 27517
        • University of North Carolina
    • North Dakota
      • Fargo, North Dakota, 미국, 58104
        • Sanford Medical Center Fargo
    • Ohio
      • Cincinnati, Ohio, 미국, 45219
        • The Christ Hospital
      • Cincinnati, Ohio, 미국, 45242
        • TriHealth-Bethesda North Hospital
      • Columbus, Ohio, 미국, 43210
        • The Ohio State University
    • Oklahoma
      • Oklahoma City, Oklahoma, 미국, 73112
        • Integris Baptist Medical Center
      • Oklahoma City, Oklahoma, 미국, 73120
        • Oklahoma Cardiovascular Research Group
      • Tulsa, Oklahoma, 미국, 74104
        • Oklahoma Heart Institute at Hillcrest Medical Center
    • Oregon
      • Portland, Oregon, 미국, 97239
        • Oregon Health & Science University
    • Pennsylvania
      • Hershey, Pennsylvania, 미국, 17033
        • Penn State Hershey
      • Philadelphia, Pennsylvania, 미국, 19104
        • Pennsylvania Presbyterian Medical Center / Hospital of the University of Pennsylvania
      • Wormleysburg, Pennsylvania, 미국, 17043
        • Pinnacle Health Cardiovascular Institute/UPMC Pinnacle
      • Wynnewood, Pennsylvania, 미국, 19096
        • Lankenau Heart Institute
    • South Carolina
      • Charleston, South Carolina, 미국, 29245
        • Medical University of South Carolina
    • Tennessee
      • Chattanooga, Tennessee, 미국, 37403
        • Erlanger Health System
      • Nashville, Tennessee, 미국, 37212
        • Vanderbilt University Medical Center
    • Texas
      • Houston, Texas, 미국, 77030
        • The University of Texas Health Science Center at Houston
      • Houston, Texas, 미국, 77004
        • HCA Houston Healthcare Medical Center
      • Houston, Texas, 미국, 77030
        • Baylor College of Medicine St. Luke's Medical Center
      • Houston, Texas, 미국, 77030
        • UTHealth/Memorial Hermann Hospital
      • Plano, Texas, 미국, 75093
        • Baylor Scott & White - The Heart Hospital - Plano
    • Utah
      • Murray, Utah, 미국, 84107
        • Intermountain Medical Center
      • St. George, Utah, 미국, 84790
        • St. George Regional Hospital
    • Virginia
      • Charlottesville, Virginia, 미국, 22908
        • University of Virginia Health System
      • Richmond, Virginia, 미국, 23298
        • Virginia Commonwealth University
      • Roanoke, Virginia, 미국, 24014
        • Carilion Medical Center
    • Washington
      • Seattle, Washington, 미국, 98101
        • Virginia Mason Medical Center
      • Seattle, Washington, 미국, 98122
        • Swedish Medical Center
    • Wisconsin
      • Milwaukee, Wisconsin, 미국, 53226
        • Medical College of Wisconsin
    • British Columbia
      • Vancouver, British Columbia, 캐나다, V6Z 1Y6
        • St. Paul's Hospital
    • Ontario
      • Hamilton, Ontario, 캐나다, L8L 2X2
        • Hamilton Health Services
      • Ottawa, Ontario, 캐나다, K1Y 4Q7
        • University of Ottawa Heart Institute
      • Toronto, Ontario, 캐나다, M4N 3M5
        • Sunnybrook Health Sciences Centre
      • Toronto, Ontario, 캐나다, M5B 1W8
        • St. Michael's Hospital
    • Quebec
      • Québec, Quebec, 캐나다, G1V 4G5
        • Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Eighteen (18) years of age or older
  • Despite medical therapy, per the local Heart Team, patient has signs of TR, symptoms from TR, or prior heart failure hospitalization from TR.
  • Severe or greater tricuspid regurgitation
  • New York Heart Association (NYHA) Class II-IVa or heart failure hospitalization in the prior 12 months
  • Patient is at an intermediate or greater estimated risk of mortality with tricuspid valve surgery as determined by the cardiac surgeon with concurrence by the local Heart Team
  • Patient is able and willing to give informed consent, follow protocol procedures, and comply with follow-up visit requirements

Exclusion Criteria:

  • Tricuspid valve anatomy not evaluable by TTE or TEE

  • Tricuspid valve anatomy precludes proper device deployment and function

  • Patient with refractory heart failure requiring, advanced intervention (i.e. patient has or will need left ventricular assist device, or transplantation) (ACC/AHA Stage D heart failure)

  • Presence of trans-tricuspid pacemaker or defibrillator leads which meet one of the following:

    1. Would prevent proper TR reduction due to interaction of the lead with the leaflets
    2. Were implanted in the RV within the last 90 days prior to the point of enrollment
  • Primary non-degenerative tricuspid disease

  • Previous tricuspid valve repair or replacement that would interfere with placement of PASCAL

  • Clinically significant, untreated coronary artery disease requiring revascularization, unstable angina, evidence of acute coronary syndrome, recent myocardial infarction

  • Significant intra-cardiac mass, thrombus, or vegetation per echo core lab assessment

  • Deep vein thrombosis (DVT) or pulmonary embolism (PE) in the last 90 days

  • Recent Stroke

  • Active gastrointestinal (GI) bleeding

  • Presence of infiltrative cardiomyopathy or valvulopathy (including carcinoid, amyloidosis, sarcoidosis, hemochromatosis) or significant congenital heart disease, including but not limited to atrial septal defect, RV dysplasia, and arrhythmogenic RV

  • Need for emergent or urgent surgery for any reason, any planned cardiac surgery within the next 12 months (365 days), or any planned percutaneous cardiac procedure within the next 90 days

  • Any of the following cardiovascular procedures:

    1. Percutaneous coronary, intracardiac, or endovascular intervention within the last 30 days prior to the point of enrollment
    2. Carotid surgery within 30 days prior to the point of enrollment
    3. Direct current cardioversion within the last 30 days prior to the point of enrollment
    4. Leadless RV pacemaker implant within the last 30 days prior to the point of enrollment
    5. Cardiac surgery within 90 days prior to the point of enrollment
  • Severe aortic, mitral and/or pulmonic valve stenosis and/or regurgitation

  • Known history of untreated severe symptomatic carotid stenosis or asymptomatic carotid stenosis

  • Active endocarditis within the last 90 days or infection requiring antibiotic therapy within the last 14 days

  • Patient is oxygen-dependent or requires continuous home oxygen

  • Pregnant, breastfeeding, or planning pregnancy within the next 12 months (365 days)

  • Concurrent medical condition with a life expectancy of less than 12 months in the judgment of the Investigator

  • Patient is currently participating in another investigational biologic, drug, or device clinical study

  • Patient has other medical, social, or psychological conditions that preclude appropriate consent and follow-up, or the patient is under guardianship

  • Any patient considered to be vulnerable

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Edwards PASCAL System & OMT

Transcatheter tricuspid valve repair with the Edwards PASCAL system in patients on optimal medical therapy (OMT) with tricuspid regurgitation

Transcatheter tricuspid valve repair with the Edwards PASCAL System in patients on optimal medical therapy

다른 이름들:
  • 경피적 삼첨판막 수리(TTVr)

Transcatheter tricuspid valve repair with the Edwards PASCAL System in conjunction with OMT

Transcatheter tricuspid valve repair with the Edwards PASCAL system in patients on optimal medical therapy (OMT) with tricuspid regurgitation

활성 비교기: Optimal Medical Therapy (OMT)

Optimal medical therapy (OMT) alone in patients with tricuspid regurgitation

Optimal Medical Therapy alone in patients with tricuspid regurgitation

실험적: Single-Arm Registry

Transcatheter tricuspid valve repair with the Edwards PASCAL System in conjunction with optimal medical therapy (OMT) in patients with tricuspid regurgitation who are not eligible for randomization

Transcatheter tricuspid valve repair with the Edwards PASCAL System in patients on optimal medical therapy

다른 이름들:
  • 경피적 삼첨판막 수리(TTVr)

Transcatheter tricuspid valve repair with the Edwards PASCAL System in conjunction with OMT

Transcatheter tricuspid valve repair with the Edwards PASCAL system in patients on optimal medical therapy (OMT) with tricuspid regurgitation

실험적: Continued Access Study

Transcatheter tricuspid valve repair with the Edwards PASCAL system in patients on optimal medical therapy (OMT) with tricuspid regurgitation

Transcatheter tricuspid valve repair with the Edwards PASCAL System in patients on optimal medical therapy

다른 이름들:
  • 경피적 삼첨판막 수리(TTVr)

Transcatheter tricuspid valve repair with the Edwards PASCAL System in conjunction with OMT

Transcatheter tricuspid valve repair with the Edwards PASCAL system in patients on optimal medical therapy (OMT) with tricuspid regurgitation

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Composite endpoint including all-cause mortality, RVAD implantation or heart transplant, tricuspid valve intervention, heart failure hospitalizations, and Quality of Life improvement (measured by KCCQ score)
기간: 6 months

Comparison of number of participants with composite endpoint events between experimental and active comparator arms

6 months

2차 결과 측정

결과 측정
측정값 설명
기간
1 Grade Reduction in TR Severity
기간: 6, 12 months

Total number of participants with at least 1 grade reduction in TR severity

6, 12 months
Quality of Life (QOL) as Measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ)
기간: 3, 6, and 12 months

Change in KCCQ score from baseline

3, 6, and 12 months
All Cause Mortality
기간: 12 months, 24 months

Total number of deaths from any cause

12 months, 24 months
Death and Heart Failure Hospitalizations
기간: 12 months

Total number of deaths and hospital admissions due to heart failure

12 months
All-cause Mortality, TV Surgery or TV Interventions
기간: 24 months

Total number of deaths, TV surgeries or interventions

24 months
Right ventricular end-diastolic diameter (RVEDD mid)
기간: 12 months

Change in right ventricular end-diastolic diameter (RVEDD mid)

12 months
Major Adverse Events (MAEs)
기간: 30 days

Overall rate of Major Adverse Events (MAEs)

30 days
Reduction in TR grade
기간: Intraprocedural post-implantation

Reduction in TR severity as assessed by TEE pre- and post-implantation

Intraprocedural post-implantation
All-Cause Mortality
기간: 12 months, annually through 5 years

Total number of deaths from any cause

12 months, annually through 5 years
Heart failure hospitalizations
기간: 12 months, annually through 5 years

Total number of hospital admissions due to heart failure

12 months, annually through 5 years
Non-elective tricuspid valve re-intervenitions (percutaneous or surgical)
기간: 12 months, annually through 5 years

Total number of non-elective tricuspid valve re-interventions

12 months, annually through 5 years
Durable RVAD implantation or heart transplant
기간: 12 months, annually through 5 years

Total number of patients requiring RVAD impantantion or heart transplant

12 months, annually through 5 years
Need for paracentesis
기간: 12 months, annually through 5 years

Total nunber of patients who required paracentesis

12 months, annually through 5 years
All cause mortality or the first heart failure hospitalization for patients with massive or torrential TR at baseline
기간: 12, 24 months

Time to death or first heart failure hospitalization

12, 24 months
All-cause Hospitalizations
기간: 12 months

Number of hospitalizations for any cause

12 months

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

수사관

  • 수석 연구원: Martin B. Leon, MD, Columbia University
  • 수석 연구원: Michael J. Mack, MD, Baylor Scott and White Health
  • 연구 의자: Gorav Ailawadi, MD, University of Michigan
  • 수석 연구원: Charles Davidson, MD, Northwestern University
  • 연구 의자: Allen Anderson, MD, The University of Texas Health Science Center at San Antonio

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2019년 12월 11일

기본 완료 (추정된)

2027년 12월 31일

연구 완료 (추정된)

2031년 12월 31일

연구 등록 날짜

최초 제출

2019년 9월 18일

QC 기준을 충족하는 최초 제출

2019년 9월 18일

처음 게시됨 (실제)

2019년 9월 20일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 16일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 13일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • 2019-07

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

예

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .